Minicircle-IFNγ induces antiproliferative and antitumoral effects in human nasopharyngeal carcinoma

Clinical Cancer Research

Volumn 12, Issue 15, 2006, Pages 4702-4713

  Wu, Jiangxue ^a   Xiao, Xia ^a   Zhao, Peng ^a   Xue, Gang ^b   Zhu, Yinghui ^a   Zhu, Xiaofeng ^a   Zheng, Limin ^a   Zeng, Yixin ^a   Huang, Wenlin ^a,c  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b CHENGDU MILITARY GENERAL HOSPITAL   (China)

^c INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; PLASMID VECTOR; RECOMBINANT GAMMA INTERFERON; ANTINEOPLASTIC AGENT; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DNA SUPERCOILING; DNA VECTOR; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; GROWTH RATE; HUMAN; HUMAN CELL; MINICIRCLE VECTOR; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; SURVIVAL; XENOGRAFT; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; CELL STRAIN 3T3; DRUG SCREENING; GENE EXPRESSION REGULATION; GENE THERAPY; GENE VECTOR; GENETIC RECOMBINATION; GENETICS; METHODOLOGY; NASOPHARYNX TUMOR; STRUCTURE ACTIVITY RELATION; SURVIVAL RATE; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTERFERON TYPE II; MICE; NASOPHARYNGEAL NEOPLASMS; NIH 3T3 CELLS; RECOMBINATION, GENETIC; STRUCTURE-ACTIVITY RELATIONSHIP; SURVIVAL RATE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 33748050464     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-0520     Document Type: Article

References (50)

1. Pang KR, Wu JJ, Huang DB, Tyring SK, Baron S. Biological and clinical basis for molecular studies of interferons. Methods Mol Med 2005;116:1-23.
2. Liu M, Acres B, Balloul JM, et al. Gene-based vaccines and immunotherapeutics. Proc Natl Acad Sci USA 2004;101 Suppl:14567-71.
3. Chada S, Ramesh R, Mhashilkar AM. Cytokine- and chemokine-based gene therapy for cancer. Curr Opin Mol Ther 2003;5:463-74.
4. Ferrantini M, Belardelli F. Gene therapy of cancer with Interferon: lessons from tumor models and perspectives for clinical applications. Semin Cancer Biol 2000;10:145-57.
5. Gutterman JU. Cytokine therapeutics: lessons from Interferon α. Proc Natl Acad Sci U S A 1994;91:1198-205.
6. Sangfeit O, Erickson S, Grander D. Mechanisms of interferon-induced cell cycle arrest. Front Biosci 2000;5:0479-87.
7. Chawla-Sarkar M, Lindner DJ, Liu YF, et al. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 2003;8:237-49
8. Detjen KM, Farwig K, Welzel M, Wiedenmann B, Rosewicz S. Interferon γ inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis. Gut 2001;49:251-62.
9. Hobeika AC, Etienne W, Cruz PE, Subramaniam PS, Johnson HM. IFNγ induction of p21WAF1 in prostate cancer cells: role in cell cycle, alteration of phenotype and invasive potential. Int J Cancer 1998;77:138-45.
10. Shyu RY, Su HL, Yu JC, Jiang SY. Direct growth suppressive activity of interferon-α and -γ on human gastric cancer cells. J Surg Oncol 2000;75:122-30.
11. Yano T, Sugio K, Yamazaki K, et al. Direct IFN influence of interferon-γ on proliferation and cell-surface antigen expression of non-small cell lung cancer cells. Lung Cancer 2000;30:169-74.
12. Cullinan AE, Brandt CR. Cytokine induced apoptosis in human retinoblastoma cells. Mol Vis 2004;10:315-22.
13. Hillman GG, Slos P, Wang Y, et al. Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma. Cancer Gene Ther 2004;11:61-72.
14. Hopfner M, Sutter AP, Huether A, Ahnert-Hilger G, Scherubl H. A novel approach in the treatment of neuroendocrine gastrointestinal tumors: additive antiproliferative effects of interferon-γ and meta-iodobenzylguanidine. BMC Cancer 2004;4:23.
15. Gollob JA, Sciambi CJ, Huang Z, Dressman HK. Gene expression changes and signaling events associated with the direct antimelanoma effect of IFN-γ. Cancer Res 2005;65:8869-77.
16. Lugovic L, Situm M, Kos L. Malignant melanoma-future prospects. Acta Dermatovenerol Croat 2005;13:36-43.
17. Chan AT, Teo PM, Huang DP. Pathogenesis and treatment of nasopharyngeal carcinoma. Semin Oncol 2004;31:794-801.
18. Spano JP, Busson P, Atlan D, et al. Nasopharyngeal carcinomas: an update. Eur J Cancer 2003;39:2121-35.
19. Young LS, Murray PG. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 2003;22:5108-21.
20. Wakisaka N, Pagano JS. Epstein-Barr virus induces invasion and metastasis factors. Anticancer Res 2003;23:2133-8.
21. Weinrib L, Li JH, Donovan J, Huang D, Liu FF. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma. Cancer Gene Ther 2001;8:352-60.
22. Li JH, Lax SA, Kim J, Klamut H, Liu FF. The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1999;43:607-16.
23. Li JH, Shi W, Chia M, et al. Efficacy of targeted FasL in nasopharyngeal carcinoma. Mol Ther 2003;8:964-73.
24. Cheung ST, Huang DP, Hui AB, et al. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer 1999;83:121-6.
25. Darquet AM, Cameron B, Wils P, Scherman D, Crouzet J. A new DNA vehicle for nonviral gene delivery: supercoiled minicircle. Gene Ther 1997;4:1341-9.
26. Darquet AM, Rangara R, Kreiss P, et al. Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer. Gene Ther 1999;6:209-18.
27. Bigger BW, Tolmachov O, Collombet JM, Fragkos M, Palaszewski I, Coutelle C. An araC-controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy. J Biol Chem 2001;276:23018-27.
28. Chen ZY, He CY, Ehrhardt A, Kay MA. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther 2003;8:495-500.
29. Chen ZY, He CY, Meuse L, Kay MA. Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo. Gene Ther 2004;11:856-64.
30. Chen ZY, He CY, Kay MA. Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo. Hum Gene Ther 2005;16:126-31.
31. Ahmed CM, Burkhart MA, Subramaniam PS, Mujtaba MG, Johnson HM. Peptide mimetics of γ interferon possess antiviral properties against vaccinia virus and other viruses in the presence of poxvirus B8R protein. J Virol 2005;79:5632-9.
32. Sakon S, Xue X, Takekawa M, et al. NF-κB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J 2003;22:3898-909.
33. Khorana AA, Rosenblatt JD, Sahasrabudhe DM, et al. A phase I trial of immunotherapy with intratumoral adenovirus-interferon-γ (TG1041) in patients with malignant melanoma. Cancer Gene Ther 2003;10:251-9.
34. Nowak AK, Lake RA, Kindler HL, Robinson BW. New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents. Semin Oncol 2002;29:82-96.
35. Gattacceca F, Pilatte Y, Billard C, et al. Ad-IFNγ induces antiproliferative and antitumoral responses in malignant mesothelioma. Clin Cancer Res 2002;8:3298-304.
36. Cordier KL, Valeyrie L, Fernandez N, et al. Regression of AK7 malignant mesothelioma established in immunocompetent mice following intratumoral gene transfer of interferon γ. Cancer Gene Ther 2003;10:481-90.
37. Dummer R, Hassel JC, Fellenberg F, et al. Adenovirus-mediated intralesional interferon-γ gene transfer induces tumor regressions in cutaneous lymphomas. Blood 2004;104:1631-8.
38. Wu CM, LiX Y, Huang TH. Anti-tumor effect of pEgr-IFNγ gene-radiotherapy in B16 melanoma-bearing mice. World J Gastroenterol 2004;10:3011-5.
39. Burke F, East N, Upton C, Patel K, Balkwill FR. Interferon γ induces cell cycle arrest and apoptosis in a model of ovarian cancer: enhancement of effect by batimastat. Eur J Cancer 1997;33:1114-21.
40. Burke F, Smith PD, Crompton MR, Upton C, Balkwill FR. Cytotoxic response of ovarian cancer cell lines to IFN-γ is associated with sustained induction of IRF-1 and p21 mRNA. Br J Cancer 1999;80:1236-44.
41. Kim EJ, Lee JM, Namkoong SE, Um SJ, Park JS. Interferon regulatory factor-1 mediates interferon-γ-induced apoptosis in ovarian carcinoma cells. J Cell Biochem 2002;85:369-80.
42. Wall L, Burke F, Barton C, Smyth J, Balkwill F. IFN-γ induces apoptosis in ovarian cancer cells in vivo and in vitro. Clin Cancer Res 2003;9:2487-96.
43. Barton C, Davies D, Balkwill F, Burke F. Involvement of both intrinsic and extrinsic pathways in IFN-γ-induced apoptosis that are enhanced with cisplatin. Eur J Cancer 2005;41:1474-86.
44. Ruiz-Ruiz C, Ruiz de Almodovar C, Rodriguez A, Ortiz-Ferron G, Redondo JM, Lopez-Rivas A. The upregulation of human caspase-8 by interferon-γ in breast tumor cells requires the induction and action of the transcription factor interferon regulatory factor-1. J Biol Chem 2004;279:19712-20.
45. Tomita Y, Bilim V, Hara N, Kasahara T, Takahashi K. Role of IRF-1 and caspase-7 in IFN-γ enhancement of Fas-mediated apoptosis in ACHN renal cell carcinoma cells. Int J Cancer 2003;104:400-8.
46. Merchant MS, Yang X, Melchionda F, et al. Interferon γ enhances the effectiveness of tumor necrosis factor-related apoptosis-inducing ligand receptor agonists in a xenograft model of Ewing's sarcoma. Cancer Res 2004;64:8349-56.
47. Papageorgiou A, Lashinger L, Millikan R, et al. Role of tumor necrosis factor-related apoptosis-inducing ligand in interferon-induced apoptosis in human bladder cancer cells. Cancer Res 2004;64:8973-9.
48. Ruiz-Ruiz C, Munoz-Pinedo C, Lopez-Rivas A. Interferon-γ treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program. Cancer Res 2000;60:5673-80.
49. Farber JM. Migand IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 1997;61:246-57.
50. Sgadari C, Angiolillo AL, Tostato G. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein-10. Blood 1996;87:3877-81.